This federal contract opportunity has been awarded to on March 19, 2026.
DEPT OF DEFENSE awarded this contract to for $1,405,309 on March 19, 2026, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
Requirement was awarded as a sole source award, FFP for reagents and consumable under authority Title 41 United States Code (U.S.C.) 1901 as implemented in Federal Acquisition Regulation (FAR) 12.102(b), restricting competition for acquisitions valued over the Simplified Acquisition Threshold.
The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in JBSA FT SAM HOUSTON, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.
Looking for more opportunities?
Browse our full directory of government contracts